Latest Period
Q4 2025
Security Snapshot
GSK plc - SPONSORED ADR (GSK) Institutional Ownership
CUSIP: 37733W204
13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026
Institutions Reporting
981
Shares (Excl. Options)
397,672,316
Price
$49.04
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / SPONSORED ADR
- Symbol
- GSK on NYSE
- Price per share
- $58.21
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 397,672,316
- Total reported value
- $19,504,054,480
- % of total 13F portfolios
- 0.02%
- Share change
- +11,026,823
- Value change
- +$561,188,548
- Number of holders
- 981
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- GSK - GSK plc - SPONSORED ADR is tracked under CUSIP 37733W204.
- 981 institutions reported positions in Q4 2025.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 981 to 481 between Q4 2025 and Q1 2026.
- Reported value moved from $19,504,054,480 to $1,389,896,629.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 981 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 37733W204?
CUSIP 37733W204 identifies GSK - GSK plc - SPONSORED ADR in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 37733W204:
As of 31 Dec 2025, 981 institutional investors reported holding 397,672,316 shares of GSK plc - SPONSORED ADR (GSK).
Institutional Holders of GSK plc - SPONSORED ADR (GSK) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 25,156,240 | $1,389,896,629 | -$281,614,142 | $55.19 | 481 |
| 2025 Q4 | 397,672,316 | $19,504,054,480 | +$561,188,548 | $49.04 | 981 |
| 2025 Q3 | 385,810,445 | $16,653,456,346 | +$149,628,861 | $43.16 | 883 |
| 2025 Q2 | 377,323,511 | $14,492,600,704 | +$691,641,935 | $38.40 | 873 |
| 2025 Q1 | 365,061,086 | $14,138,125,686 | +$1,006,993,911 | $38.74 | 839 |
| 2024 Q4 | 340,917,752 | $11,541,588,389 | +$1,180,300,325 | $33.82 | 833 |
| 2024 Q3 | 302,968,498 | $12,377,977,607 | -$140,106,119 | $40.88 | 883 |
| 2024 Q2 | 309,126,756 | $11,909,339,872 | -$23,346,819 | $38.50 | 869 |
| 2024 Q1 | 308,583,941 | $13,222,947,461 | +$833,173,631 | $42.87 | 891 |
| 2023 Q4 | 289,484,844 | $10,732,131,887 | +$174,194,109 | $37.06 | 882 |
| 2023 Q3 | 284,245,298 | $10,307,406,122 | +$264,432,361 | $36.25 | 835 |
| 2023 Q2 | 276,495,626 | $9,857,311,052 | +$194,467,459 | $35.64 | 814 |
| 2023 Q1 | 269,710,676 | $9,600,329,935 | -$208,079,525 | $35.58 | 792 |
| 2022 Q4 | 276,203,256 | $9,708,565,984 | +$516,369,806 | $35.14 | 788 |
| 2022 Q3 | 264,324,002 | $7,785,299,734 | +$7,652,922,694 | $29.43 | 697 |
| 2022 Q2 | 4,250,301 | $185,367,037 | +$183,087,502 | $43.53 | 67 |
| 2022 Q1 | 52,302 | $2,281,067 | -$356,058 | $43.56 | 7 |
| 2021 Q4 | 60,336 | $2,667,168 | -$139,973 | $44.10 | 7 |
| 2021 Q3 | 17,405 | $671,931 | +$7,790 | $38.21 | 6 |
| 2021 Q2 | 17,188 | $691,875 | -$30,222 | $39.82 | 6 |
| 2021 Q1 | 17,949 | $649,577 | +$393,265 | $35.69 | 6 |
| 2020 Q4 | 7,178 | $264,151 | -$29,072 | $36.80 | 4 |
| 2020 Q3 | 7,968 | $299,261 | +$325 | $37.64 | 4 |
| 2020 Q2 | 7,971 | $325,296 | -$17,284 | $40.79 | 3 |
| 2020 Q1 | 8,394 | $316,305 | -$7,502 | $37.89 | 3 |
| 2019 Q4 | 8,592 | $403,759 | +$47 | $46.99 | 3 |
| 2019 Q3 | 6,012 | $256,603 | +$43 | $42.68 | 2 |
| 2019 Q2 | 6,011 | $240,560 | +$280 | $40.02 | 2 |
| 2019 Q1 | 6,004 | $250,926 | -$58,469 | $41.79 | 2 |
| 2018 Q4 | 7,403 | $282,874 | -$23,957 | $38.21 | 2 |
| 2018 Q3 | 8,030 | $322,558 | -$357,464 | $40.17 | 2 |
| 2018 Q2 | 16,929 | $682,392 | +$81 | $40.31 | 2 |
| 2018 Q1 | 16,927 | $661,338 | +$10,158 | $39.07 | 2 |
| 2017 Q4 | 16,667 | $591,179 | -$47,282 | $35.47 | 2 |
| 2017 Q3 | 18,000 | $730,800 | -$109,620 | $40.60 | 2 |
| 2017 Q2 | 20,700 | $892,584 | $43.12 | 2 | |
| 2017 Q1 | 20,700 | $872,712 | $42.16 | 2 | |
| 2016 Q4 | 20,700 | $797,157 | +$182,191 | $38.51 | 2 |
| 2016 Q3 | 15,969 | $688,743 | +$10,783 | $43.13 | 2 |
| 2016 Q2 | 15,719 | $681,261 | -$56,342 | $43.34 | 2 |
| 2016 Q1 | 17,019 | $690,120 | $40.55 | 2 |